neostigmine has been researched along with Retinal Pigment Epithelial Detachment in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, KO | 1 |
| Heimann, K | 1 |
| Kyrieleis, E | 1 |
| Kanski, JJ | 1 |
3 other studies available for neostigmine and Retinal Pigment Epithelial Detachment
| Article | Year |
|---|---|
Central anticholinergic syndrome following reversal of neuromuscular blockade.
Topics: Anesthesia, General; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Parasympatholyt | 1993 |
[Retinal detachment from miotic therapy].
Topics: Adult; Age Factors; Aged; Chronic Disease; Female; Glaucoma; Humans; Male; Middle Aged; Miotics; Neo | 1970 |
Miotics.
Topics: Acetylcholine; Anterior Chamber; Carbachol; Cataract; Cholinesterase Inhibitors; Cysts; Echothiophat | 1968 |